A novel knock-in mouse reveals mechanistically distinct forms of morphine tolerance

Johan Enquist1, Joseph A Kim, Selena Bartlett

  • 1Ernest Gallo Clinic and Research Center, 5858 Horton St., Emeryville, CA 94608, USA.

Insights

Investigating μ-opioid receptor (MOR) down-regulation in morphine tolerance, this study reveals that receptor degradation accelerates tolerance but reduces dependence. Wild-type MOR mice develop tolerance slower with less dependence and no receptor down-regulation.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Molecular Biology

Background:

  • The role of μ-opioid receptor (MOR) down-regulation in the development of opioid tolerance is not fully understood.
  • Existing research presents conflicting findings regarding the direct link between MOR down-regulation and the extent of opioid tolerance.

Purpose of the Study:

  • To investigate how varying degrees of MOR down-regulation impact the development of morphine tolerance using a novel knock-in mouse model.
  • To differentiate between tolerance mediated by receptor down-regulation and other mechanisms of morphine tolerance.

Main Methods:

  • Generation of a novel knock-in mouse model expressing a mutant degrading MOR (DMOR) that is targeted for degradation upon internalization, unlike wild-type (WT) MOR.
  • Comparative analysis of morphine tolerance, dependence, and MOR expression levels between WT MOR and DMOR mice after morphine administration.
  • Assessment of receptor internalization and degradation following morphine activation in both WT and DMOR mice.

Main Results:

  • DMOR mice exhibited a more rapid onset of morphine tolerance accompanied by significant MOR down-regulation compared to WT MOR mice.
  • WT MOR mice developed morphine tolerance more slowly, and profound tolerance was observed without significant MOR down-regulation.
  • WT MOR mice displayed significantly higher morphine dependence, indicated by withdrawal symptoms, after long-term treatment compared to DMOR mice.

Conclusions:

  • Tolerance mediated by MOR down-regulation has distinct behavioral and biochemical manifestations compared to morphine tolerance in WT mice.
  • Receptor down-regulation is not a primary contributor to morphine tolerance in WT MOR mice.
  • Altering the extent of MOR down-regulation influences the development of morphine tolerance and dependence, suggesting distinct underlying mechanisms.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.